News & Press release

Contribution from UHREG

https://immutol-horizon.eu/wp-content/uploads/2024/05/GiuliaPreverin_publicengagement-e1717084452127.jpg 519 382 IMMUTOL IMMUTOL https://immutol-horizon.eu/wp-content/uploads/2024/05/GiuliaPreverin_publicengagement-e1717084452127.jpg March 30, 2024 May 30, 2024

March 30, 2024

In 26th February 2024 UHREG’s Doctoral Candidate Giulia Preverin participated in a career information day at one of Regensburg’s high schools, the Albertus-Magnus-Gymnasium. The aim of the event was to…

Prof. Eva Martínez-Cáceres at Immunodays 2024

https://immutol-horizon.eu/wp-content/uploads/2024/12/4-Madrid-cosa-vedere-nel-2023-tra-architettura-design-arte-indirizzi-livingcorriere-04-e1734350171105-1024x587.jpg 1024 587 IMMUTOL IMMUTOL https://immutol-horizon.eu/wp-content/uploads/2024/12/4-Madrid-cosa-vedere-nel-2023-tra-architettura-design-arte-indirizzi-livingcorriere-04-e1734350171105-1024x587.jpg March 11, 2024 December 16, 2024

March 11, 2024

Prof. Eva Martínez-Cáceres, MD, from IGTP, gave an invited talk entitled ‘Immunotherapy with autologous tolerogenic dendritic cells for treatment of autoimmune diseases’ at Immunodays (Madrid) 2024.

Prof. Eva Martínez-Cáceres at the 22nd Annual Conference Laboratory Medicine

https://immutol-horizon.eu/wp-content/uploads/2024/12/3-Eva-Martinez-Caceres_Egyptian-Society-of-Laboratory-Medicine-1024x1024.jpg 1024 1024 IMMUTOL IMMUTOL https://immutol-horizon.eu/wp-content/uploads/2024/12/3-Eva-Martinez-Caceres_Egyptian-Society-of-Laboratory-Medicine-1024x1024.jpg February 22, 2024 December 16, 2024

February 22, 2024

Prof. Eva Martínez-Cáceres, MD from IGTP was invited to the 22nd Annual Conference Laboratory Medicine. Egyptian Society of Laboratory Medicine (Egypt). The talk presented online was entitled ‘Immunotherapy with autologous tolerogenic…

1st Annual Meeting in Barcelona on 6th and 7th June 2024

https://immutol-horizon.eu/wp-content/uploads/2023/05/shutterstock_131332256-1024x842.jpg 1024 842 IMMUTOL IMMUTOL https://immutol-horizon.eu/wp-content/uploads/2023/05/shutterstock_131332256-1024x842.jpg February 6, 2024 February 6, 2024

February 6, 2024

SAVE THE DATE! IMMUTOL 1st Annual Meeting will be held on 6th and 7th June 2024 in Barcelona at IQS facilities.

Press Release from IQS about the start of the IMMUTOL project

https://immutol-horizon.eu/wp-content/uploads/2023/05/Immutol_logo-1-1024x411.png 1024 411 IMMUTOL IMMUTOL https://immutol-horizon.eu/wp-content/uploads/2023/05/Immutol_logo-1-1024x411.png October 21, 2023 June 21, 2024

October 21, 2023

Press Release: English https://techtransfer.iqs.edu/en/news/new-effective-therapies-for-multiple-sclerosis/ Spanish https://techtransfer.iqs.edu/actualidad/nuevas-terapias-efectivas-para-la-esclerosis-multiple/ Catalan https://techtransfer.iqs.edu/ca/actualitat/noves-terapies-efectives-per-lesclerosi-multiple/

IMMUTOL Kick off meeting on 24th and 25th of May 2023 in Milan

https://immutol-horizon.eu/wp-content/uploads/2023/05/IMMUTOL_Kick-of-photo_for-TOBU-1024x768.jpg 1024 768 IMMUTOL IMMUTOL https://immutol-horizon.eu/wp-content/uploads/2023/05/IMMUTOL_Kick-of-photo_for-TOBU-1024x768.jpg May 24, 2023 July 3, 2023

May 24, 2023

The IMMUTOL Consortium, led by Silvia Gregori (San Raffaele Telethon Institute for Gene Therapy– SR-TIGET) successfully kicked-off the project at a hybrid event, held at the Fondazione Telethon, Milano (Italy),…